Cargando…

Efficacy of Low-Dose Paroxetine for the Treatment of Hot Flushes in Surgical and Physiological Postmenopausal Women: Systematic Review and Meta-Analysis of Randomized Trials

Background and Objectives: Hot flushes and sleep disturbances are the most common vasomotor symptoms (VMS) reported by postmenopausal women. Hormonal treatment is to date referred to as the gold standard approach but not suitable for all the patients. Alternative treatments are needed in case of a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Riemma, Gaetano, Schiattarella, Antonio, La Verde, Marco, Zarobbi, Giuseppina, Garzon, Simone, Cucinella, Gaspare, Calagna, Gloria, Labriola, Domenico, De Franciscis, Pasquale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780738/
https://www.ncbi.nlm.nih.gov/pubmed/31480427
http://dx.doi.org/10.3390/medicina55090554
_version_ 1783457208065851392
author Riemma, Gaetano
Schiattarella, Antonio
La Verde, Marco
Zarobbi, Giuseppina
Garzon, Simone
Cucinella, Gaspare
Calagna, Gloria
Labriola, Domenico
De Franciscis, Pasquale
author_facet Riemma, Gaetano
Schiattarella, Antonio
La Verde, Marco
Zarobbi, Giuseppina
Garzon, Simone
Cucinella, Gaspare
Calagna, Gloria
Labriola, Domenico
De Franciscis, Pasquale
author_sort Riemma, Gaetano
collection PubMed
description Background and Objectives: Hot flushes and sleep disturbances are the most common vasomotor symptoms (VMS) reported by postmenopausal women. Hormonal treatment is to date referred to as the gold standard approach but not suitable for all the patients. Alternative treatments are needed in case of a contraindication to menopausal hormone therapy (MHT), adverse side effects, and poor compliance. Paroxetine salt is the only nonhormonal medication approved by the US Food and Drug Administration for the management of VMS. Nonetheless, few trials with low consensus are available about this topic. In this review, we aimed to evaluate the efficacy of low-dose paroxetine therapy in the treatment of vasomotor hot flushes and night sleep disturbances in postmenopausal women. Materials and Methods: We performed an electronic search from the beginning of all databases to July 2019. All results were then limited to a randomized trial. Restrictions for language or geographic location were not utilized. Inclusion criteria were randomized clinical trials of physiological or surgical postmenopausal women experiencing hot flushes and sleep disturbances who were randomized to either low-dose paroxetine or placebo (i.e., formulations without active ingredients). The primary outcome evaluated was the mean weekly reduction of hot flushes. Results: Five randomized clinical trials, including 1482 postmenopausal women, were analyzed. Significant heterogeneity (I(2) = 90%) between studies was noted. Hot flushes episodes were significantly reduced in the treatment arm compared to placebo (mean difference (MD) −7.97 [−10.51, −5.92] episodes/week). Results on the improvement on sleep were limited by being reported in only two studies; however, no significant reduction of night-time awakenings was observed (MD, −0.40 awakenings/night [−1.38, 0.58 CI]). Conclusions: Low-dose paroxetine is an effective treatment for vasomotor menopause symptoms, including hot flushes.
format Online
Article
Text
id pubmed-6780738
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67807382019-10-30 Efficacy of Low-Dose Paroxetine for the Treatment of Hot Flushes in Surgical and Physiological Postmenopausal Women: Systematic Review and Meta-Analysis of Randomized Trials Riemma, Gaetano Schiattarella, Antonio La Verde, Marco Zarobbi, Giuseppina Garzon, Simone Cucinella, Gaspare Calagna, Gloria Labriola, Domenico De Franciscis, Pasquale Medicina (Kaunas) Review Background and Objectives: Hot flushes and sleep disturbances are the most common vasomotor symptoms (VMS) reported by postmenopausal women. Hormonal treatment is to date referred to as the gold standard approach but not suitable for all the patients. Alternative treatments are needed in case of a contraindication to menopausal hormone therapy (MHT), adverse side effects, and poor compliance. Paroxetine salt is the only nonhormonal medication approved by the US Food and Drug Administration for the management of VMS. Nonetheless, few trials with low consensus are available about this topic. In this review, we aimed to evaluate the efficacy of low-dose paroxetine therapy in the treatment of vasomotor hot flushes and night sleep disturbances in postmenopausal women. Materials and Methods: We performed an electronic search from the beginning of all databases to July 2019. All results were then limited to a randomized trial. Restrictions for language or geographic location were not utilized. Inclusion criteria were randomized clinical trials of physiological or surgical postmenopausal women experiencing hot flushes and sleep disturbances who were randomized to either low-dose paroxetine or placebo (i.e., formulations without active ingredients). The primary outcome evaluated was the mean weekly reduction of hot flushes. Results: Five randomized clinical trials, including 1482 postmenopausal women, were analyzed. Significant heterogeneity (I(2) = 90%) between studies was noted. Hot flushes episodes were significantly reduced in the treatment arm compared to placebo (mean difference (MD) −7.97 [−10.51, −5.92] episodes/week). Results on the improvement on sleep were limited by being reported in only two studies; however, no significant reduction of night-time awakenings was observed (MD, −0.40 awakenings/night [−1.38, 0.58 CI]). Conclusions: Low-dose paroxetine is an effective treatment for vasomotor menopause symptoms, including hot flushes. MDPI 2019-08-31 /pmc/articles/PMC6780738/ /pubmed/31480427 http://dx.doi.org/10.3390/medicina55090554 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Riemma, Gaetano
Schiattarella, Antonio
La Verde, Marco
Zarobbi, Giuseppina
Garzon, Simone
Cucinella, Gaspare
Calagna, Gloria
Labriola, Domenico
De Franciscis, Pasquale
Efficacy of Low-Dose Paroxetine for the Treatment of Hot Flushes in Surgical and Physiological Postmenopausal Women: Systematic Review and Meta-Analysis of Randomized Trials
title Efficacy of Low-Dose Paroxetine for the Treatment of Hot Flushes in Surgical and Physiological Postmenopausal Women: Systematic Review and Meta-Analysis of Randomized Trials
title_full Efficacy of Low-Dose Paroxetine for the Treatment of Hot Flushes in Surgical and Physiological Postmenopausal Women: Systematic Review and Meta-Analysis of Randomized Trials
title_fullStr Efficacy of Low-Dose Paroxetine for the Treatment of Hot Flushes in Surgical and Physiological Postmenopausal Women: Systematic Review and Meta-Analysis of Randomized Trials
title_full_unstemmed Efficacy of Low-Dose Paroxetine for the Treatment of Hot Flushes in Surgical and Physiological Postmenopausal Women: Systematic Review and Meta-Analysis of Randomized Trials
title_short Efficacy of Low-Dose Paroxetine for the Treatment of Hot Flushes in Surgical and Physiological Postmenopausal Women: Systematic Review and Meta-Analysis of Randomized Trials
title_sort efficacy of low-dose paroxetine for the treatment of hot flushes in surgical and physiological postmenopausal women: systematic review and meta-analysis of randomized trials
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780738/
https://www.ncbi.nlm.nih.gov/pubmed/31480427
http://dx.doi.org/10.3390/medicina55090554
work_keys_str_mv AT riemmagaetano efficacyoflowdoseparoxetineforthetreatmentofhotflushesinsurgicalandphysiologicalpostmenopausalwomensystematicreviewandmetaanalysisofrandomizedtrials
AT schiattarellaantonio efficacyoflowdoseparoxetineforthetreatmentofhotflushesinsurgicalandphysiologicalpostmenopausalwomensystematicreviewandmetaanalysisofrandomizedtrials
AT laverdemarco efficacyoflowdoseparoxetineforthetreatmentofhotflushesinsurgicalandphysiologicalpostmenopausalwomensystematicreviewandmetaanalysisofrandomizedtrials
AT zarobbigiuseppina efficacyoflowdoseparoxetineforthetreatmentofhotflushesinsurgicalandphysiologicalpostmenopausalwomensystematicreviewandmetaanalysisofrandomizedtrials
AT garzonsimone efficacyoflowdoseparoxetineforthetreatmentofhotflushesinsurgicalandphysiologicalpostmenopausalwomensystematicreviewandmetaanalysisofrandomizedtrials
AT cucinellagaspare efficacyoflowdoseparoxetineforthetreatmentofhotflushesinsurgicalandphysiologicalpostmenopausalwomensystematicreviewandmetaanalysisofrandomizedtrials
AT calagnagloria efficacyoflowdoseparoxetineforthetreatmentofhotflushesinsurgicalandphysiologicalpostmenopausalwomensystematicreviewandmetaanalysisofrandomizedtrials
AT labrioladomenico efficacyoflowdoseparoxetineforthetreatmentofhotflushesinsurgicalandphysiologicalpostmenopausalwomensystematicreviewandmetaanalysisofrandomizedtrials
AT defranciscispasquale efficacyoflowdoseparoxetineforthetreatmentofhotflushesinsurgicalandphysiologicalpostmenopausalwomensystematicreviewandmetaanalysisofrandomizedtrials